Susquehanna International Group’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-107,069
| Closed | -$317K | – | 11173 |
|
|
2019
Q3 | $317K | Buy |
+107,069
| New | +$220K | ﹤0.01% | 8187 |
|
|
2017
Q4 | – | Sell |
-3,313
| Closed | -$29K | – | 10223 |
|
|
2017
Q3 | $51K | Buy |
3,313
+670
| +25% | +$10.8K | ﹤0.01% | 8535 |
|
|
2017
Q2 | $53K | Sell |
2,643
-66
| -2% | -$814 | ﹤0.01% | 8875 |
|
|
2017
Q1 | $27K | Buy |
+2,709
| New | +$30.1K | ﹤0.01% | 8689 |
|
|
2016
Q1 | – | Sell |
-2,100
| Closed | -$143K | – | 10003 |
|
|
2015
Q4 | $143K | Buy |
+2,100
| New | +$151K | ﹤0.01% | 8679 |
|
|
2015
Q2 | – | Sell |
-1,986
| Closed | -$134K | – | 10647 |
|
|
2015
Q1 | $134K | Buy |
+1,986
| New | +$128K | ﹤0.01% | 8858 |
|
|
2014
Q3 | – | Sell |
-1,500
| Closed | -$90K | – | 10208 |
|
|
2014
Q2 | $90K | Buy |
+1,500
| New | +$83.7K | ﹤0.01% | 9453 |
|
|
2013
Q4 | – | Sell |
-9,645
| Closed | -$634K | – | 9514 |
|
|
2013
Q3 | $634K | Buy |
+9,645
| New | +$780K | ﹤0.01% | 6059 |
|
Susquehanna International Group's FCSC Position: Q4 2019 in Review
Susquehanna International Group sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 107,069 shares — an estimated $317K sold.
Susquehanna International Group first reported a position in FCSC in Q3 2013 and held it in 8 quarters. The position peaked at $634K in Q3 2013. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Susquehanna International Group reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 107,069 Fibrocell Science Inc. shares in Q4 2019, an estimated $317K.
- Susquehanna International Group first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 8 quarters.
- Susquehanna International Group's Fibrocell Science Inc. position peaked at $634K in Q3 2013.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.